Procaps Group, S.A. (PROCW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2022 | 28.41 Million USD | -84.1% |
| 2021 | 178.72 Million USD | -47.39% |
| 2020 | 339.73 Million USD | 6.02% |
| 2019 | 320.46 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q2 | 169.63 Million USD | 13.08% |
| 2023 Q1 | 150.01 Million USD | 428.02% |
| 2023 Q3 | 220.68 Million USD | 30.09% |
| 2022 FY | 28.41 Million USD | -84.1% |
| 2022 Q1 | 168.63 Million USD | -5.65% |
| 2022 Q4 | 28.41 Million USD | -83.37% |
| 2022 Q2 | 181.81 Million USD | 7.82% |
| 2022 Q3 | 170.81 Million USD | -6.05% |
| 2021 Q1 | 350.14 Million USD | 3.06% |
| 2021 FY | 178.72 Million USD | -47.39% |
| 2021 Q4 | 178.72 Million USD | 75.33% |
| 2021 Q3 | 101.93 Million USD | -73.31% |
| 2021 Q2 | 381.91 Million USD | 9.08% |
| 2020 Q4 | 339.73 Million USD | 0.0% |
| 2020 FY | 339.73 Million USD | 6.02% |
| 2019 FY | 320.46 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 90.826% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | 68.806% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 94.202% |
| Dynavax Technologies Corporation | 252.41 Million USD | 88.745% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 94.336% |
| Cosmos Health Inc. | 3.03 Million USD | -835.974% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 94.471% |
| PainReform Ltd. | 30 Thousand USD | -94600.0% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -5170.53% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -5170.53% |
| SCYNEXIS, Inc. | 12.15 Million USD | -133.654% |
| Safety Shot Inc | 304.9 Thousand USD | -9217.595% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -24155.308% |
| Alpha Teknova, Inc. | 13.25 Million USD | -114.399% |
| Embecta Corp. | 1.62 Billion USD | 98.252% |
| Bright Green Corporation | 201.78 Thousand USD | -13979.481% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -113.192% |
| Journey Medical Corporation | 14.62 Million USD | -94.296% |
| Theratechnologies Inc. | 51.26 Million USD | 44.578% |
| Harrow Health, Inc. | 183.17 Million USD | 84.49% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -32555.172% |
| Biofrontera Inc. | 804 Thousand USD | -3433.582% |
| DURECT Corporation | 2.7 Million USD | -951.443% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 14.417% |
| Cronos Group Inc. | 1.55 Million USD | -1722.322% |
| OptiNose, Inc. | 611 Thousand USD | -4549.755% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 94.299% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | 16.906% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -6143.956% |
| Organogenesis Holdings Inc. | 60.74 Million USD | 53.231% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -122.228% |
| Radius Health, Inc. | 339.66 Million USD | 91.636% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | -176.955% |
| Phibro Animal Health Corporation | 458.28 Million USD | 93.801% |
| Procaps Group S.A. | 28.41 Million USD | 0.0% |
| Alvotech | 1.02 Billion USD | 97.236% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -334.936% |
| Viatris Inc. | 16.18 Billion USD | 99.825% |
| Rockwell Medical, Inc. | 8.29 Million USD | -242.578% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -161.193% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -8355.584% |
| Tilray Brands, Inc. | 287.93 Million USD | 90.133% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 76.425% |
| Shineco, Inc. | 10.01 Million USD | -183.608% |
| PetIQ, Inc. | 437.82 Million USD | 93.511% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -13428.571% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 89.001% |
| Alimera Sciences, Inc. | 64.48 Million USD | 55.946% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | 26.235% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -20930.58% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -314.299% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -3845.833% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -126256.52% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | 13.278% |
| Hempacco Co., Inc. | 5.93 Million USD | -379.009% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 97.236% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 49.463% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 95.389% |
| Currenc Group, Inc. | 2.5 Million USD | -1033.239% |
| Kamada Ltd. | 7.43 Million USD | -281.958% |
| Indivior PLC | 235.66 Million USD | 87.945% |
| Evoke Pharma, Inc. | 5 Million USD | -468.2% |
| Flora Growth Corp. | 942 Thousand USD | -2915.924% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -126256.52% |
| Evolus, Inc. | 120.35 Million USD | 76.396% |
| HUTCHMED (China) Limited | 48.18 Million USD | 41.045% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 95.178% |
| Akanda Corp. | 2.49 Million USD | -1037.695% |